Henan Newland Pharmaceutical Co. Ltd. A (301277) — Free Cash Flow Generation Index
Henan Newland Pharmaceutical Co. Ltd. A (301277) has a Free Cash Flow Generation Index of 0.13x as of December 2025. Free cash flow of CN¥15.55 Million represents 0% of operating cash flow (CN¥116.94 Million). Explore Henan Newland Pharmaceutical Co. Ltd. A (301277) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Henan Newland Pharmaceutical Co. Ltd. A Free Cash Flow Generation Index (2020–2025)
Historical FCF Generation Index trend for Henan Newland Pharmaceutical Co. Ltd. A across 6 annual periods. For the full cash flow conversion analysis, see Henan Newland Pharmaceutical Co. Ltd. A (301277) cash conversion ratio.
Annual Free Cash Flow Generation for Henan Newland Pharmaceutical Co. Ltd. A (2020–2025)
Year-by-year Free Cash Flow Generation Index for Henan Newland Pharmaceutical Co. Ltd. A. Check 301277 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.13x | CN¥15.55 Million | CN¥116.94 Million | CN¥101.38 Million | ▲ +5.6% |
| 2024 | 0.13x | CN¥15.97 Million | CN¥126.76 Million | CN¥110.79 Million | ▼ -79.9% |
| 2023 | 0.63x | CN¥162.94 Million | CN¥259.46 Million | CN¥96.51 Million | ▲ +511.9% |
| 2022 | 0.10x | CN¥8.50 Million | CN¥82.85 Million | CN¥74.34 Million | ▼ -78.7% |
| 2021 | 0.48x | CN¥23.68 Million | CN¥49.08 Million | CN¥25.40 Million | ▼ -25.3% |
| 2020 | 0.65x | CN¥30.90 Million | CN¥47.86 Million | CN¥16.96 Million | — |